[go: up one dir, main page]

HK1213594A1 - 免疫原性組合物及其用途 - Google Patents

免疫原性組合物及其用途

Info

Publication number
HK1213594A1
HK1213594A1 HK15112748.3A HK15112748A HK1213594A1 HK 1213594 A1 HK1213594 A1 HK 1213594A1 HK 15112748 A HK15112748 A HK 15112748A HK 1213594 A1 HK1213594 A1 HK 1213594A1
Authority
HK
Hong Kong
Prior art keywords
immunogenic compositions
immunogenic
compositions
Prior art date
Application number
HK15112748.3A
Other languages
English (en)
Inventor
再成．莊
劉家齊
郭孟欣
張瑞原
Original Assignee
Nat Health Research Institutes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Health Research Institutes filed Critical Nat Health Research Institutes
Publication of HK1213594A1 publication Critical patent/HK1213594A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1009—Picornaviridae, e.g. hepatitis A virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32361—Methods of inactivation or attenuation
    • C12N2770/32363—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HK15112748.3A 2010-08-17 2012-09-25 免疫原性組合物及其用途 HK1213594A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/858,007 US9051361B2 (en) 2010-08-17 2010-08-17 Immunogenic compositions and uses thereof

Publications (1)

Publication Number Publication Date
HK1213594A1 true HK1213594A1 (zh) 2016-07-08

Family

ID=45594260

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112748.3A HK1213594A1 (zh) 2010-08-17 2012-09-25 免疫原性組合物及其用途

Country Status (4)

Country Link
US (1) US9051361B2 (zh)
CN (2) CN104946604A (zh)
HK (1) HK1213594A1 (zh)
TW (1) TWI481717B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201405559TA (en) * 2012-03-09 2014-11-27 Inst Pasteur Shanghai Cas Component and method for treating viral disease
CN104694479B (zh) * 2012-07-13 2018-05-04 厦门大学 肠道病毒71型的vp2抗原的中和表位多肽及其用途
MA41506A (fr) * 2015-02-13 2017-12-19 Takeda Vaccines Inc Procédés de production de virus pour produire des vaccins
EP3085774A1 (en) * 2015-04-20 2016-10-26 QIAGEN GmbH Method for concentrating, purifying and/or isolating virus particles
CN105759033A (zh) * 2016-03-29 2016-07-13 中国医学科学院医学生物学研究所 一种Cox A16及EV71病毒抗原的鉴别检测方法
CN106119209B (zh) * 2016-07-01 2019-10-25 武汉爱博泰克生物科技有限公司 一种抗肠道病毒EV71 IgA单克隆抗体及应用
CN106421770B (zh) * 2016-11-11 2019-12-06 中山大学 包含ev71vp1蛋白的纳米颗粒及其制备方法
WO2019008599A1 (en) * 2017-07-03 2019-01-10 Bharat Biotech International Limited VACCINE COMPOSITION BASED ON SYNTHETIC POLYPEPTIDE EPITOPE
CN108267577B (zh) * 2018-01-15 2020-10-09 广州市妇女儿童医疗中心 一种EV71病毒IgA抗体检测试纸条
CN109929032A (zh) * 2019-02-26 2019-06-25 青岛今墨堂生物技术有限公司 一种抗手足口病鸡卵黄抗体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719051A (en) 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
MXPA05013141A (es) * 2003-06-09 2006-03-17 Wyeth Corp Metodo mejorado para la recuperacion de arn virus de cadena negativa, no segmentados, a partir de adnc.
CN101402944B (zh) * 2008-11-17 2010-12-22 中国医学科学院医学生物学研究所 一种ev-71病毒毒种、人用灭活疫苗及其制备方法
US8168192B2 (en) * 2008-11-19 2012-05-01 National Chung Hsing University Enterovirus type 71 protein and method for production
CN101717754B (zh) * 2009-12-30 2012-09-05 北京科兴生物制品有限公司 一种71型肠道病毒及其应用

Also Published As

Publication number Publication date
US9051361B2 (en) 2015-06-09
TW201209166A (en) 2012-03-01
CN102399757A (zh) 2012-04-04
US20120045468A1 (en) 2012-02-23
CN104946604A (zh) 2015-09-30
TWI481717B (zh) 2015-04-21

Similar Documents

Publication Publication Date Title
IL277110A (en) Immunogenic anti-inflammatory preparations
ZA201209259B (en) Uses and compositions
GB201003924D0 (en) Immunogenic composition
GB201006096D0 (en) Novel compositions and uses thereof
EP2550307A4 (en) MACRO-PHOTOINITIATORS AND COMPOSITIONS CURABLE THEREOF
EP2646468A4 (en) ANTI-NGF COMPOSITIONS AND THEIR USE
PH12013500698A1 (en) Hair-mending compositions and associated methods
IL223153A0 (en) Compositions comprising acid and derivatives thereof and uses thereof
PL2579839T3 (pl) Kompozycje perfumeryjne i ich zastosowania
SI2605757T1 (sl) Formulacije na osnovi nalbufina in njihove uporabe
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
HK1213594A1 (zh) 免疫原性組合物及其用途
GB201015132D0 (en) Vaccine composition
GB201113770D0 (en) Novel compositions and uses thereof
GB201005625D0 (en) Immunogenic proteins and compositions
IL242592A (en) Immunogenic compounds
GB201103423D0 (en) Immunogenic proteins and compositions
HK1173657A1 (zh) 免疫組合物和方法
EP2515940A4 (en) IMMUNOGENIC COMPOSITIONS AND CORRESPONDING METHODS
GB201018650D0 (en) Methods and compositions
HK1201451A1 (zh) 組合物及其製備方法
EP2588118B8 (en) Constrained immunogenic compositions and uses therefor
EP2640418A4 (en) IMMUNOGENIC COMPOSITIONS
ZA201301908B (en) Immunogenic compositions
GB201005826D0 (en) New compositions and their use